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Background
Potently-neutralizing, anti-MPER humoral responses are
uncommon in AIDS patients, though some anti-MPER
antibodies, like 4E10, are broadly cross-reactive and pro-
tective in combination passive immunizations. The diffi-
culty in raising these specificities may be the result of
steric occlusion of this region on virions and/or 'masking'
of the epitopes by some means; understanding these
mechanisms, and the mechanisms by which anti-MPER
antibodies neutralize, are critical in the selection and
design of vaccine immunogens targeting this region.
Methods
The Stamatatos CAVD consortium has used computa-
tional methods to design isolated epitope-scaffold pro-
teins that effectively present the 4E10 epitope, as defined
by binding to 4E10 with tight affinities (determined using
surface plasmon resonance) and conservation of epitope
structure (using macromolecular crystallography).
Results
Many of the 4E10-based epitope-scaffold proteins show
multimerization in solution by a variety of biophysical
techniques, with the 4E10 epitope itself buried at the mul-
timer interface. We conclude that many of these proteins
are in rapid monomer/multimer equilibration in solution
since 4E10 can bind tightly to many of these species. Bur-
ial of the epitope, however, may affect presentation dur-
ing immunization and formulation for immunization
may affect the equilibrium.
Conclusion
We are exploring the possibility that 4E10 epitope self-
association may also explain 'masking' in context of the
virion, using epitope-scaffold proteins as surrogates for
Env protein in studies of the effects of resistance muta-
tions in this region. These studies reveal another potential
mechanism of epitope masking, where conserved, sensi-
tive surfaces on the Env MPER are hidden through self-
associations and only transiently exposed to the immune
system, either though rapid dynamic equilibria or
induced conformational changes.
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